Matches RNA sequencing results to the treatments most likely to produce an effective response.
Consented intake · your records travel with you · nothing moves without your sign-off
Genomic Expression performs RNA sequencing on tumor tissue to find transcriptome abnormalities that may inform treatment, and uses biomarker-drug matching to recommend the options most likely to work based on the disease profile. It is built for patients who want their molecular data translated into concrete treatment ideas rather than raw results.
Prefer the source? Genomic Expression's own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Genomic Expression handles billing.
We don't have confirmed insurance details for Genomic Expression yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Genomic's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
Uncover any abnormalities in the transcriptome that may inform treatment
This page is general information. Upload your records for analysis specific to YOUR diagnosis.